Asset Details
Do you wish to reserve the book?
Biocompatibility in hemodialysis: artificial membrane and human blood interactions
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Biocompatibility in hemodialysis: artificial membrane and human blood interactions
Do you wish to request the book?
Biocompatibility in hemodialysis: artificial membrane and human blood interactions
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Biocompatibility in hemodialysis: artificial membrane and human blood interactions
2025
Overview
Hemodialysis, a cornerstone therapy for chronic kidney disease, represented a crucial advance in the evolution of artificial organs. While its success is largely due to its efficiency in removing uremic toxins, an equally important challenge is to uphold the
primum non nocere
principle by minimizing the harmful effects of membrane–blood interactions. This review examines the complex mechanisms and key interactions underlying membrane biocompatibility, including complement activation, inflammation, and coagulation disturbances, paving the way for their clinical implications. We also summarize recent innovations in membrane materials and surface engineering aimed at improving hemocompatibility and promoting safer hemodialysis treatments for improved clinical outcomes.
Highlights
Membrane biocompatibility is essential for safe and effective hemodialysis, while bioincompatibility can trigger complement activation, inflammation, and coagulation disorders.
Synthetic membranes generally demonstrate superior hemocompatibility compared with cellulose-based membranes.
Adverse immune and inflammatory responses to membrane–blood interactions may contribute to oxidative stress, endothelial dysfunction, and immune exhaustion, impacting patient prognosis.
Advances in membrane design and surface engineering offer promising strategies to improve safety and clinical outcomes.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
